TD Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
SUT
TD Asset Management's CELL Position: Q1 2022 in Review
TD Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 41,117 shares — an estimated $748K sold.
TD Asset Management first reported a position in CELL in Q3 2020 and held it in 6 quarters. The position peaked at $1.87M in Q2 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.
- TD Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- TD Asset Management sold 41,117 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $748K.
- TD Asset Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 6 quarters.
- TD Asset Management's PhenomeX Inc. Common Stock position peaked at $1.87M in Q2 2021.
- 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.
Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.